Literature DB >> 2593833

Augmentation of protein degradation by L-triiodothyronine in uremia.

V S Lim1, E Tsalikian, M J Flanigan.   

Abstract

To ascertain if excessive protein catabolism is a feature of uremia, we determined leucine flux and nitrogen balance in 11 stable chronic dialysis patients and in 7 normal subjects. Leucine flux was determined during primed constant infusion of 2H3 and 15N leucine. Nitrogen balance was determined by measurement of nitrogen in the food, dialysate, and urine, and in the dialysis patients by correcting for the changing urea nitrogen pool. To assess if thyroid hormone adversely affects protein metabolism, the above-mentioned studies were done once in the basal state and once after a 7-day course of L-triiodothyronine (T3) treatment. Leucine carbon flux (mumol/kg/min) was 1.22 +/- 0.05 in the controls and 1.40 +/- 0.09 in the renal patients in the basal state (P = NS). Following T3 treatment, leucine carbon flux was increased to 1.40 +/- 0.05 and 1.72 +/- 0.09, respectively, in the controls and the renal patients (P less than .05). Fractional increment of the leucine carbon flux was 14% +/- 3% in the controls and 23% +/- 9% in the renal patients (P less than .05). The leucine nitrogen flux (mumol/kg/min) was 2.10 +/- 0.15 in the controls and 2.54 +/- 0.23 in the renal patients in the basal state (P = NS), and increased to 2.48 +/- 0.14 and 3.44 +/- 0.22, respectively, in controls and renal patients after T3 administration (P less than .05). Fractional increment of leucine nitrogen flux was 19.5% +/- 4.3% in the controls and 36.4% +/- 5.0% in the renal patients (P less than .05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2593833     DOI: 10.1016/0026-0495(89)90161-3

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  5 in total

Review 1.  Nonthyroidal illness and the cardiorenal syndrome.

Authors:  Christiaan L Meuwese; Olaf M Dekkers; Peter Stenvinkel; Friedo W Dekker; Juan J Carrero
Journal:  Nat Rev Nephrol       Date:  2013-09-03       Impact factor: 28.314

Review 2.  Thyroid and aging.

Authors:  Mouhammed Habra; Nicholas J Sarlis
Journal:  Rev Endocr Metab Disord       Date:  2005-05       Impact factor: 6.514

Review 3.  An update for the controversies and hypotheses of regulating nonthyroidal illness syndrome in chronic kidney diseases.

Authors:  Gaosi Xu; Wenjun Yan; Jingzhen Li
Journal:  Clin Exp Nephrol       Date:  2014-04-22       Impact factor: 2.801

4.  Low T3 syndrome and long-term mortality in chronic hemodialysis patients.

Authors:  Stylianos Fragidis; Konstantinos Sombolos; Elias Thodis; Stylianos Panagoutsos; Euthymia Mourvati; Maria Pikilidou; Aikaterini Papagianni; Ploumis Pasadakis; Vasilios Vargemezis
Journal:  World J Nephrol       Date:  2015-07-06

5.  Insulin resistance is a significant determinant of sarcopenia in advanced kidney disease.

Authors:  Serpil M Deger; Jennifer R Hewlett; Jorge Gamboa; Charles D Ellis; Adriana M Hung; Edward D Siew; Cindy Mamnungu; Feng Sha; Aihua Bian; Thomas G Stewart; Naji N Abumrad; T Alp Ikizler
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-06-12       Impact factor: 4.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.